Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 1, 1994
Serological tumor markers for small cell lung cancer and their therapeutic implicationsA J Vangsted
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1A J Vangsted, J Zeuthen
The Journal of Clinical Endocrinology and Metabolism|June 1, 1990
Production of gastrin-releasing peptide-(18-27) and a stable fragment of its precursor in small cell lung carcinoma cellsA J Vangsted, T W Schwartz
Breast Cancer Research and Treatment|October 1, 1991
Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancerA J Vangsted, E V Andersen, L Nedergaard, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Early infections in patients undergoing high-dose treatment with stem cell support: a comparison of patients with non-Hodgkin lymphoma and multiple myelomaA O Gang, M Arpi, Uffe J O Gang, et al.
Cancer Research|June 1, 1991
Immunochemical detection of a small cell lung cancer-associated ganglioside (FucGM1) antigen in serumA J Vangsted, H Clausen, T B Kjeldsen, et al.
Gene|November 11, 2017
Drug response prediction in high-risk multiple myelomaA J Vangsted, S Helm-Petersen, J B Cowland, et al.
Scandinavian Journal of Immunology|November 4, 2010
Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⁻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myelomaM K Brimnes, A J Vangsted, L M Knudsen, et al.
International Journal of Laboratory Hematology|March 31, 2016
Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translationN E U Hermansen, R Borup, M K Andersen, et al.
Bone Marrow Transplantation|November 11, 2008
The polymorphism IL-1beta T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCTA J Vangsted, T W Klausen, W Ruminski, et al.
Pageof 1